Pdb59 - Cost-Effectiveness of Switching to Insulin Degludec (Ideg) U100 From Currently Available Basal Insulins in Belgium Based on Evidence From Real-World Clinical Practice
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.764
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV